4,614 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
JNJ Johnson & Johnson $139.96 $375.48B Uptrend
Article Searches
Pharma Stock Roundup: Regulatory Updates From MRK, PFE, J&J, AGN & Others http://www.zacks.com/stock/news/359854/pharma-stock-roundup-regulatory-updates-from-mrk-pfe-jj-agn-others?cid=CS-ZC-FT-359854 Mar 15, 2019 - Regulatory updates from J&J (JNJ), Merck (MRK), Roche (RHHBY), Pfizer (PFE) and others.
J&J Seeks Approval for Darzalex in Expanded Patient Group http://www.zacks.com/stock/news/359663/jj-seeks-approval-for-darzalex-in-expanded-patient-group?cid=CS-ZC-FT-359663 Mar 15, 2019 - J&J (JNJ) files sBLA seeking approval for Darzalex combination regimen in newly- diagnosed, transplant ineligible multiple myeloma patient population.
Company News For Mar 15, 2019 http://www.zacks.com/stock/news/359794/company-news-for-mar-15-2019?cid=CS-ZC--359794 Mar 15, 2019 - Companies In The News Are: BA, DG, JNJ, WAGE
Cramer: Five 'perils' of investing in individual stocks https://www.cnbc.com/2019/03/14/cramer-five-perils-of-investing-in-individual-stocks.html Mar 14, 2019 - Jim Cramer takes a look at some of the biggest headlines of the week that have rocked stocks on the market.
Johnson & Johnson (JNJ) Presents at Barclays Global Healthcare Broker Conference Call - (Transcript) https://seekingalpha.com/article/4248819-johnson-and-johnson-jnj-presents-barclays-global-healthcare-broker-conference-call-transcript?source=feed_sector_healthcare Mar 14, 2019 - Johnson & Johnson (NYSE:JNJ) Barclays Global Healthcare Conference Call March 14, 2019, 10:15 ET Company Participants Lesley Fishman - IR Chris DelOrefice - VP, IR Catherine Owen - President, Immu
Stock Market Update: Johnson & Johnson Underperforms Related to Baby Powder Case http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=SI20190314122634 Mar 14, 2019 - It's been a range-bound session today with the S&P 500 trading between a loss o...
Minnesota man who threw meth-filled 'death party' for wife now facing murder charge http://www.nydailynews.com/news/crime/ny-news-minnesota-meth-death-party-murder-charge-20190314-story.html Mar 14, 2019 -

A 58-year-old Minnesota man who threw a meth-filled "death party" for his wife has now been charged with murder.

Duane Johnson was initially jailed for criminal neglect after his wife died in January, but a new charge of third-degree murder has been added after an autopsy found that Debra Johnson...

B2Gold Corp (BTG) CEO Clive Johnson on Q4 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4248673-b2gold-corp-btg-ceo-clive-johnson-q4-2018-results-earnings-call-transcript?source=feed_sector_transcripts Mar 14, 2019 - B2Gold Corp (NYSEMKT:BTG) Q4 2018 Earnings Conference Call March 13, 2019, 13:00 ET Company Participants Clive Johnson - President, CEO & Director Michael Cinnamond - SVP, Finance & CFO Willia
Johnson & Johnson ordered to pay $29 million to woman who says company's baby powder gave her terminal cancer http://www.nydailynews.com/news/national/ny-news-johnson-johnson-lawsuit-judgment-20190314-story.html Mar 14, 2019 -

Pharma giant Johnson & Johnson suffered yet another major legal setback on Wednesday when it was ordered to pay $29 million to a woman who says the company's baby powder gave her terminal cancer.

A Superior Court jury in Oakland, Calif., found that the powder was a “substantial contributing factor”...

Melinta Therapeutics, Inc. (MLNT) CEO John Johnson on Q4 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4248622-melinta-therapeutics-inc-mlnt-ceo-john-johnson-q4-2018-results-earnings-call-transcript?source=feed_sector_healthcare Mar 13, 2019 - Melinta Therapeutics, Inc. (NASDAQ:MLNT) Q4 2018 Earnings Conference Call March 13, 2019 4:30 PM Company Participants Susan Blum - Vice President, Finance John Johnson - Chief Executive Officer and Di

Pages: 1234567...462

<Page 2>